Fox RJ - Search Results

1

Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: a detailed protocol.

Whitfield HJ Jr, Brady LS, Smith MA, Mamalaki E, Fox RJ, Herkenham M. Whitfield HJ Jr, et al. Among authors: fox rj. Cell Mol Neurobiol. 1990 Mar;10(1):145-57. doi: 10.1007/BF00733641. Cell Mol Neurobiol. 1990. PMID: 2334945

2

Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications.

Brady LS, Whitfield HJ Jr, Fox RJ, Gold PW, Herkenham M. Brady LS, et al. Among authors: fox rj. J Clin Invest. 1991 Mar;87(3):831-7. doi: 10.1172/JCI115086. J Clin Invest. 1991. PMID: 1671867 Free PMC article.

3

Refining the treatment of women with unstable angina--a randomized, double-blind, comparative safety and efficacy evaluation of Integrelin versus aspirin in the management of unstable angina.

Goldschmidt-Clermont PJ, Schulman SP, Bray PF, Chandra NC, Grigoryev D, Dise KR, Sagar M, Fox RJ, Coleman LD, Richardson C, Dorsey FC, du Mee C, Kitt MM, Ouyang P, Baughman KL, Gerstenblith G. Goldschmidt-Clermont PJ, et al. Among authors: fox rj. Clin Cardiol. 1996 Nov;19(11):869-74. doi: 10.1002/clc.4960191106. Clin Cardiol. 1996. PMID: 8914780 Clinical Trial.

4

Sources of Cannabis Information and Medical Guidance for Neurologic Use: NARCOMS Survey of People Living With Multiple Sclerosis.

Salter A, Cutter G, Marrie RA, Nichol K, Steinerman JR, Smith KMJ, Fox RJ. Salter A, et al. Among authors: fox rj. Neurol Clin Pract. 2022 Apr;12(2):102-112. doi: 10.1212/CPJ.0000000000001155. Neurol Clin Pract. 2022. PMID: 35733947 Free PMC article.

5

A double-blind, randomized, placebo-controlled phase 2 trial evaluating the selective dihydroorotate dehydrogenase inhibitor vidofludimus calcium in relapsing-remitting multiple sclerosis.

Fox RJ, Wiendl H, Wolf C, De Stefano N, Sellner J, Gryb V, Rejdak K, Bozhinov PS, Tomakh N, Skrypchenko I, Muehler AR. Fox RJ, et al. Ann Clin Transl Neurol. 2022 Jun 14. doi: 10.1002/acn3.51574. Online ahead of print. Ann Clin Transl Neurol. 2022. PMID: 35698927 Free article.

6

Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis.

Fox RJ, Mehta R, Pham T, Park J, Wilson K, Bonafede M. Fox RJ, et al. BMC Neurol. 2022 Jun 7;22(1):211. doi: 10.1186/s12883-022-02738-7. BMC Neurol. 2022. PMID: 35672686 Free PMC article.

7

Siponimod vs placebo in active secondary progressive multiple sclerosis: a post hoc analysis from the phase 3 EXPAND study.

Gold R, Piani-Meier D, Kappos L, Bar-Or A, Vermersch P, Giovannoni G, Fox RJ, Arnold DL, Benedict RHB, Penner IK, Rouyrre N, Kilaru A, Karlsson G, Ritter S, Dahlke F, Hach T, Cree BAC. Gold R, et al. Among authors: fox rj. J Neurol. 2022 May 31. doi: 10.1007/s00415-022-11166-z. Online ahead of print. J Neurol. 2022. PMID: 35639197 Free article.

8

Attitudes toward coronavirus disease 2019 vaccination in people with multiple sclerosis.

Marrie RA, Dolovich C, Cutter GR, Fox RJ, Salter A. Marrie RA, et al. Among authors: fox rj. Mult Scler J Exp Transl Clin. 2022 May 22;8(2):20552173221102067. doi: 10.1177/20552173221102067. eCollection 2022 Apr-Jun. Mult Scler J Exp Transl Clin. 2022. PMID: 35634013 Free PMC article.

9

Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years.

Cree BA, Arnold DL, Fox RJ, Gold R, Vermersch P, Benedict RH, Bar-Or A, Piani-Meier D, Rouyrre N, Ritter S, Kilaru A, Karlsson G, Giovannoni G, Kappos L. Cree BA, et al. Among authors: fox rj. Mult Scler. 2022 Apr 5:13524585221083194. doi: 10.1177/13524585221083194. Online ahead of print. Mult Scler. 2022. PMID: 35380078

10

High-Strength Liquid Crystal Polymer-Graphene Oxide Nanocomposites from Water.

Fox RJ, Hegde M, Cole DP, Moore RB, Picken SJ, Dingemans TJ. Fox RJ, et al. ACS Appl Mater Interfaces. 2022 Apr 13;14(14):16592-16600. doi: 10.1021/acsami.2c00186. Epub 2022 Mar 24. ACS Appl Mater Interfaces. 2022. PMID: 35330991

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results